Clay Siegall: An Important Figure In The Fight Against Cancer

Clay Siegall is the Founder and Chief Executive Officer of Seattle Genetics. He is also the president of the company and also a member of its Board of Directors. Founded in 1998, Seattle Genetics is a firm which is focused on developing a broad range of clinical and preclinical drugs. Their target candidates are mainly victims of cancer and other autoimmune diseases. Dr. Siegall has provided excellent leadership in Seattle Genetics, making it one of the leading institutions on the fight against cancer.
Clay Siegall has also been significantly involved with the funding of Seattle Genetics. He helped to come up with over300 million us dollars in capital from both private and public funding. The firm has also been placed on the top of antibody technologies. Under the able leadership of Clay Siegall, the company has succeeded in getting FDA approval for their Antibody-drug conjugates (ADC)-technology based drugs.

Dr. Clay Siegall is a scientist by training and founded Seattle Genetics on principles of scientific foundations, drug development practices, and rigorous research. Clay is more focused on cancer therapies. His ADCs technology has helped to develop medicines which may change the future of cancer and autoimmune diseases patient’s future for good. He has nearly 20 years of vast experience in the cancer research as well as therapeutic drug development.

Before he co-founded Seattle Genetics, Dr. Clay worked with the Bristol-Myers Squibb Pharmaceutical Research Institute, National Institute of Health as well as the National Cancer Institute. Clay Siegall is also a member of the Board of Directors of Ultragenyx Pharmaceuticals, Mirna Therapeutics, Washington Roundtable and Alder pharmaceuticals. Due to his efforts towards cancer, Dr. Siegall is an important figure in the fight against cancer.

Clay Siegall is seen as a committed and competent professional. According to robsonvalleytimes.com, Seattle Genetics will employ more employees and expand its drug production to have more impact on patients all over the nation. Siegall has a great passion for helping patients; this makes his services efficient and centered more on the wellbeing of the patients.

Leave a Reply